FOXE1
Summary: This intronless gene encodes a protein that belongs to the forkhead family of transcription factors. Members of this family contain a conserved 100-amino acid DNA-binding 'forkhead' domain. The encoded protein functions as a thyroid transcription factor that plays a role in thyroid morphogenesis. Mutations in this gene are associated with the Bamforth-Lazarus syndrome, and with susceptibility to nonmedullary thyroid cancer-4. [provided by RefSeq, Nov 2016].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| forkhead box E1 | MIM:602617 | Ensembl:ENSG00000178919 | HGNC:HGNC:3806 | PA28223 | 9q22.33 |
GO terms in FOXE1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IBA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | IDA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | IMP | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | ISM | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | NAS | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | IDA | GO:0003700 | DNA-binding transcription factor activity |
| MF | IDA | GO:0043565 | sequence-specific DNA binding |
| MF | IMP | GO:0043565 | sequence-specific DNA binding |
| BP | ISS | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | NAS | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
| BP | IBA | GO:0006357 | regulation of transcription by RNA polymerase II |
| BP | IDA | GO:0006357 | regulation of transcription by RNA polymerase II |
| BP | IMP | GO:0006357 | regulation of transcription by RNA polymerase II |
| BP | ISS | GO:0006590 | thyroid hormone generation |
| BP | IBA | GO:0009653 | anatomical structure morphogenesis |
| BP | NAS | GO:0009653 | anatomical structure morphogenesis |
| BP | ISS | GO:0016477 | cell migration |
| BP | IBA | GO:0030154 | cell differentiation |
| BP | IEP | GO:0030878 | thyroid gland development |
| BP | IMP | GO:0030878 | thyroid gland development |
| BP | ISS | GO:0031069 | hair follicle morphogenesis |
| BP | ISS | GO:0045892 | negative regulation of transcription, DNA-templated |
| BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
| BP | IEP | GO:0048538 | thymus development |
| BP | ISS | GO:0048562 | embryonic organ morphogenesis |
| BP | IMP | GO:0060022 | hard palate development |
| BP | IMP | GO:0060023 | soft palate development |
| BP | IEP | GO:0060465 | pharynx development |
| BP | IEA | GO:1904888 | cranial skeletal system development |
| CC | IBA | GO:0005634 | nucleus |
| CC | IDA | GO:0005634 | nucleus |
Gene expression in normal tissue: FOXE1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in FOXE1
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD132 | (-)-gallocatechin-3-O-gallate | 4 |
| iGMDRD154 | NSC23766 | 3 |
| iGMDRD446 | LY 2183240 | 4 |
| iGMDRD341 | Triacsin c | 2 |
| iGMDRD144 | NSC95397 | 5 |
| iGMDRD494 | Neopeltolide | 3 |
| iGMDRD330 | BRD4132 | 3 |
| iGMDRD889 | Compound 7d-cis | 6 |
| iGMDRD300 | Tozasertib | 2 |
| iGMDRD886 | Compound 1541A | 3 |
| iGMDRD60 | Quinoclamine | 3 |
| iGMDRD268 | Cerulenin | 3 |
| iGMDRD286 | Nsc 632839 | 3 |
| iGMDRD188 | Piperlongumine | 8 |
| iGMDRD872 | BRD7137 | 5 |
| iGMDRD577 | BIX01294 | 3 |
| iGMDRD77 | Itraconazole | 5 |
| iGMDRD474 | Avrainvillamide | 2 |
| iGMDRD137 | Indisulam | 2 |
| iGMDRD255 | SB225002 | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in FOXE1

